Design and implement real-world evidence programs to strengthen the target product profile, address payer evidence needs and support market access across geographies, including systematic literature reviews, evidence synthesis, natural history and real-world data analyses, registry strategies, and post-launch evidence plans. This leader will play a pivotal role in shaping payer evidence generation and will oversee global pharmacoeconomic models, evidence synthesis, disease registries, observational and retrospective research, external HEOR partnerships, and data-gap identification needed to support a compelling health-economic value proposition.